Biogen Inc. (0R1B.L) LSE

188.03

-6.97(-3.57%)

Updated at June 02 06:24PM

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Christopher A. Viehbacher	President, Chief Executive Officer & Director	5.28M	1961
Rachid Izzar	Executive Vice President and Head of Global Product Strategy & Commercialization	1.27M	1975
Ginger Gregory	Executive Vice President & Chief Human Resources Officer	1.59M	1968
Robin C. Kramer	Executive Vice President & Chief Financial Officer	1.63M	1966
Priya Singhal	Executive Vice President & Head of Development	2.01M	1968
Nicole Murphy	Executive Vice President and Head of Pharmaceutical Operations & Technology	2.01M	1973
Susan H. Alexander	Executive Vice President & Chief Legal Officer	2.25M	1957
Anabella Villalobos	Head of Biotherapeutics & Medicinal Sciences	0	1960
Adam Keeney	Executive Vice President & Head of Corporate Development	0	1977
Tim Power	Head of Investor Relations	0	N/A
Natacha Gassenbach	Chief Communication Officer & Head of Corporate Affairs	0	N/A
Fraser Hall	President & Head of Intercontinental Region	0	N/A
Alisha A. Alaimo	President & Head of North America	0	N/A
Guy Hadari	Chief Information Officer	0	N/A
Sean Godbout	VP, Chief Accounting Officer & Global Corporate Controller	0	1974

Name

Title

Pay

Year Born

Christopher A. Viehbacher

President, Chief Executive Officer & Director

5.28M

1961

Rachid Izzar

Executive Vice President and Head of Global Product Strategy & Commercialization

1.27M

1975

Ginger Gregory

Executive Vice President & Chief Human Resources Officer

1.59M

1968

Robin C. Kramer

Executive Vice President & Chief Financial Officer

1.63M

1966

Priya Singhal

Executive Vice President & Head of Development

2.01M

1968

Nicole Murphy

Executive Vice President and Head of Pharmaceutical Operations & Technology

2.01M

1973

Susan H. Alexander

Executive Vice President & Chief Legal Officer

2.25M

1957

Anabella Villalobos

Head of Biotherapeutics & Medicinal Sciences

1960

Adam Keeney

Executive Vice President & Head of Corporate Development

1977

Tim Power

Head of Investor Relations

N/A

Natacha Gassenbach

Chief Communication Officer & Head of Corporate Affairs

N/A

Fraser Hall

President & Head of Intercontinental Region

N/A

Alisha A. Alaimo

President & Head of North America

N/A

Guy Hadari

Chief Information Officer

N/A

Sean Godbout

VP, Chief Accounting Officer & Global Corporate Controller

1974

Description

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees. The firm focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The firm markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). The company also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The firm's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.